Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 6, 2003, Pages 963-972

  Pees, Christiane ^a   Unger, Thomas ^b   Gohlke, Peter ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

AT1 receptor antagonist; AT2 receptor; Bradykinin; Cyclic GMP; Nitric oxide

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; CYCLIC GMP; ICATIBANT; LOSARTAN; MINOXIDIL; N(G) NITROARGININE METHYL ESTER; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; NITRIC OXIDE SYNTHASE; PYRIDINE DERIVATIVE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; IMMUNOREACTIVITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; RAT; ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; DRUG ANTAGONISM; METABOLISM; VASCULAR ENDOTHELIUM; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; CYCLIC GMP; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; IMIDAZOLES; LOSARTAN; MALE; MINOXIDIL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PYRIDINES; RATS; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

EID: 0141834774     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00265-0     Document Type: Article

References (41)

1. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye J.A., Smith R.D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:1993;205-251.
2. Unger T., Chung O., Cikos T., Culman J., Gallinat S., Gohlke P., Höhle S., Meffert S., Stoll M., Stroth U., Zhu Y.Z. Angiotensin receptors. J. Hypertens. 14(Suppl. 15):1996;S95-S103.
3. Griendling K.K., Lassègue B., Alexander R.W. Angiotensin receptors and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 36:1997;281-306.
4. Gohlke P., Lamberty V., Kuwer I., Bartenbach S., Schnell A., Linz W., Schölkens B.A., Wiemer G., Unger T. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3′,5′-monophosphate. Hypertension. 22:1993;682-687.
5. Gohlke P., Linz W., Schölkens B.A., Kuwer I., Bartenbach S., Schnell A., Unger T. Angiotensin converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 23:1994;411-418.
6. Gohlke P., Kuwer I., Bartenbach S., Schnell A., Unger T. Effect of low-dose treatment with perindopril on cardial function in stroke-prone spontaneously hypertensive rats: role of bradykinin. J. Cardiovasc. Pharmacol. 24:1994;462-469.
7. Gohlke P., Linz W., Schölkens B.A., Wiemer G., Unger T. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension. 28:1996;397-402.
8. Campbell D.J., Kladis A., Valentijn A.J. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J. Cardiovasc. Pharmacol. 26:1995;233-240.
9. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 31(Part 2):1998;349-355.
10. Tsutsumi Y., Matsubara H., Masaki H., Kurihara H., Murasawa S., Takai S., Miyazaki M., Nozawa Y., Ozono R., Nakagawa K., Miwa T., Kawada N., Mori Y., Shibasaki Y., Tanaka Y., Fujiyama S., Koyama Y., Fujiyama A., Takahashi H., Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104:1999;925-935.
11. 2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm. Pharmacol. Lett. 3:1993;24-27.
12. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 26:1995;752-757.
13. Seyedi N., Xu X.B., Nasjiletti A., Hintze T.H. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 26:1995;164-170.
14. 2 production in conscious rats. J. Clin. Invest. 97:1996;1978-1982.
15. 2-receptor activation, bradykinin and prostaglandins in pigs. J. Am. Coll. Cardiol. 32:1998;1787-1796.
16. Liu Y.H., Yand X.P., Sharov V.G., Nass O., Sabbah H.N., Peterson E., Carretero O.A. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. J. Clin. Invest. 99:1997;1926-1935.
17. Scheuer D.A., Perrone M.H. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol. 264:1993;R917-R923.
18. Munzenmaier D.H., Greene A.S. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension. 27(Part 2):1996;760-765.
19. Endo Y., Arima S., Yaoita H., Tsunoda K., Omata K., Ito S. Vasodilation mediated by angiotensin II type 2 receptors is impaired in afferent arterioles of young spontaneously hypertensive rats. J. Vasc. Res. 35:1998;421-427.
20. 1 receptor antagonist in hypertensive rats. Hypertension. 35:1999;1112-1116.
21. 2 receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins. Eur. J. Pharmacol. 394:2000;103-108.
22. Ca) channels. Hypertension. 37:2001;301-307.
23. 2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. Eur. J. Pharmacol. 259:1994;27-36.
24. 2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest. 98:1996;418-425.
25. 2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension. 31(Part 2):1998;487-492.
26. 1 receptors in the rat. Am. J. Physiol. 274:1998;E115-E123.
27. Schuijt M.P., de Vries R., Saxena P.R., Danser A.H.J. No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats. J. Hypertens. 17:1999;1879-1884.
28. 2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension. 33(Part 2):1999;366-372.
29. 1 receptor antagonist, EXP 3174. Br. J. Pharmacol. 107:1992;873-880.
30. Ichiki T., Labosky P.A., Shiota C., Okuyama S., Imagawa Y., Fogo A., Niimura F., Ichikawa I., Hogan B.L.M., Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 377:1995;748-750.
31. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin type-2 receptor gene in mice. Nature. 377:1995;744-747.
32. Admiraal P.J.J., Derkx F.H.M., Danser A.H.J., Pieterman H., Schalekamp M.A.D.H. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension. 15:1990;44-55.
33. Otsuka S., Sugano M., Makino N., Sawada S., Hata T., Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension. 32:1998;467-472.
34. Nora E.H., Munzenmaier D.H., Hansen-Smith F.M., Lombard J.H., Greene A.S. Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am. J. Physiol. 275:1998;H1395-H1403.
35. Viswanathan M., Tsutsumi K., Correa F.M.A., Saavedra J.M. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun. 179:1991;1361-1367.
36. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95:1995;651-657.
37. 1 receptors in endothelial cells. Br. J. Pharmacol. 118:1996;79-84.
38. 2) receptor protein in rat heart. Hypertension. 32:1998;78-83.
39. Kambayashi Y., Bardhan S., Inagami T. Peptide growth factor markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle. Biochem. Biophys. Res. Commun. 194:1993;478-482.
40. Wong P.C., Price W.A., Chiu A.T., Duncia J.V., Carini D.J., Wexler R.R., Johnson A.L., Timmermans P.B.M.W.M. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Hypertension. 15:1990;459-468.
41. Guan H., Cachofeiro V., Pucci M.L., Kaminski P.M., Wolin M.S., Nasjletti A. Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension. 27:1996;19-24.